Table 4

- Univariate analysis on the relationship between preoperative medication (single vs. dual antiplatelet therapy) and baseline and postoperative variables (N=54).

VariablesPreoperative medicationP-values
Single antiplatelet therapy (n=22)Dual antiplatelet therapy (n=32)
Age in years (mean±SD)66.1±8.5467.3±10.80.663
Gender
Male13 (59.1)18 (56.3)1.00
Female9 (4.9)14 (43.8)
Smoking status
Smoker5 (22.7)6 (18.8)0.743
Non-smoker17 (77.3)26 (81.3)
Risk factors*
HTN13 (59.1)25 (78.1)0.225
DM18 (81.8)21 (65.6)0.23
IHD13 (59.1)6 (18.8)0.004§
PAD7 (31.8)3 (9.4)0.071
DLP11 (50.0)12 (37.5)0.411
CHF4 (18.2)2 (06.3)0.211
Previous stroke3 (13.6)13 (40.8)0.039§
Presenting symptoms*
Asymptomatic7 (31.8)6 (18.8)0.338
Hemiparesis7 (31.8)13 (40.6)0.576
Ataxia4 (18.2)5 (15.6)1.00
Dysarthria9 (40.9)12 (37.5)1.00
Hemiparesthesia2 (9.1)4 (12.5)1.00
Indication for surgery
Stroke14 (63.6)16 (50.0)0.043§
TIA1 (04.5)10 (31.3) 
Asymptomatic7 (31.8)6 (18.8) 
ICU/HDU admission
Yes13 (59.1)14 (43.8)0.406
No9 (40.9)18 (56.3)
Operated side
Right side14 (63.6)15 (46.9)0.274
Left side8 (36.4)17 (53.1)
Complication
Yes4 (18.2)9 (28.1)0.523
No18 (81.8)23 (71.9)
Upon follow-up
Restenosis2 (10.0)10 (34.5)0.089
Regression of disease18 (90.0)19 (65.5)
Interval between symptoms and surgery19.5±1413.1±8.60.075
Carotid clamp time (min)5.1±3.415.5±3.530.789
ICU/HDU stay (days)3.14±6.021.19±2.070.096
Ward stay (days)12.5±13.111.6±10.20.783
Total hospital stay (days)15.6±14.912.8±11.50.437

Values are presented as numbers and precentages or mean ± standard deviation (SD).

HTN: hypertension, DM: diabetes mellitus, IHD: ischemic heart disease, PAD: peripheral artery disease, DLP: dyslipidemia, CHF: congestive heart failure, TIA: transient ischemic attack, ICU: intensive care unit, HDU: high dependency unit

  • * Some patients had more than one risk factor or symptom.

  • P-value was calculated using Fischer’s exact test.

  • P-value was calculated using an independent sample t-test.

  • § Significant at P<0.05 level.